Expansions of trinucleotide or hexanucleotide repeats lead to several neurodegenerative disorders including Huntington disease (HD, caused by the expanded CAG repeats (CAGr) in the HTT gene) and amyotrophic lateral sclerosis (ALS, could be caused by the expanded GGGGCC repeats (G4C2r) in the C9ORF72 gene), of which the molecular mechanisms remain unclear. Here we demonstrate that loss of the Drosophila orthologue of tau protein (dtau) significantly rescued in vivo neurodegeneration, motor performance impairments, and shortened life-span in Drosophila models expressing mutant HTT protein with expanded CAGr or the expanded G4C2r. Importantly, expression of human tau (htau4R) restored the disease-relevant phenotypes that were mitigated by the loss of dtau, suggesting a conserved role of tau in neurodegeneration. We further discovered that G4C2r expression increased dtau accumulation, possibly due to reduced activity of BAG3-mediated autophagy. Our study reveals a conserved role of tau in G4C2r-induced neurotoxicity in Drosophila models, providing mechanistic insights and potential therapeutic targets.
INTRODUCTION
An expansion mutation of the GGGGCC repeat (G4C2) within intron 1 of C9orf72 is a common mutation associated with of sporadic amyotrophic lateral sclerosis (ALS) and frontotemporal dementia Drosophila models have been widely used to study genetic neurodegenerative disorders, especially CAG expansion and GGGGCC expansion diseases, probably because of their monogenetic nature.
Many of the genetic or chemical modifiers identified in these models have been validated in patient cells and mammalian models. In this study, we first characterized the pathophysiological function of Drosophila orthologue of tau (dtau) in HD models. We confirmed a conserved role of dtau in HD neurotoxicity by showing that the loss of dtau significantly rescued phenotypes in HD Drosophila models expressing human mutant HTT protein (mHTT) exon1 fragment, consistent with the observation in an HD mouse model expressing the mHTT exon1 fragment (Fernandez-Nogales et al., 2014). We then investigated the potential role of dtau in G4C2-induced neurotoxicity in Drosophila models, and explored tau-relevant pathogenic mechanisms.
RESULTS dtau knockout rescued HD-relevant phenotypes including in vivo neurodegeneration, behavioral deficits and shortened life-span in Drosophila models.
In order to capture the neuronal morphology relatively clearly in the Drosophila brain in vivo, we utilized a simple UAS-GAL4 system to express membrane GFP markers (mCD8GFP) in a very small group of neurons by GMR61G12-GAL4, so that their morphology could be clearly observed. We detected the in vivo HD-relevant neurodegeneration by observing the loss of major axon bundles in the GFP labeled by neurons induced by expression of human mHTT but not wtHTT exon1 fragment (HTT.ex1.Q72 versus HTT.ex1.Q25, Fig. S1A ). The neurodegeneration occurs in both dendrites and axons ( Figure S2 ).
At the whole animal level, expressing mutant HTTexon1 (HTT.ex1.Q72) by the pan neural driver elav-GAL4 caused motor performance impairments and shortened life-span compared to ones expressing the wild-type version (HTT.ex1.Q25, Figure S1B -C), recapitulating HD-relevant phenotypes in patients.
We then investigated the potential role of tau in HD by testing the knockout of the Drosophila tau gene to eliminate the expression of dtau. Drosophila tau is the homolog of human MAPT, the gene expressing the tau protein. The dtau knockout line we utilized was previously reported to present a specific deletion of the genetic region spanning from exon 2 to exon 6, which codes for the microtubule-binding region of dtau . Interestingly, loss of dtau significantly rescued HD-relevant in vivo neurodegeneration, behavioral deficits and shortened life-span phenotypes, suggesting that dtau mediates mHTT neurotoxicity, at least partially ( Figure S1A The study using HD models demonstrated a conserved role of dtau in neurodegeneration, and thus we investigated potential functions of dtau in expanded G4C2-induced neurotoxicity in a wellcharacterized and widely used Drosophila model expressing 30 repeats of G4C2 ((G4C2)30) . Similar as the HD Drosophila model, UAS-mCD8GFP-GAL4 driven (G4C2)30 expression led to in vivo neurodegeneration ( Figure 1A ). In addition, (G4C2)30 expression in the motor neurons driven by UAS-mCD8GFP-GAL4 led to significant reduction of neuro-muscular junctions (NMJs), which were detected by the NMJ marker Brp and axon marker HRP ( Figure 1B ). At the whole animal level, neuronal expression of (G4C2)30 driven by elav-GAL4 led to motor performance impairments and shortened life-span ( Figure 1C -D). Loss of dtau significantly mitigated all these disease-relevant phenotypes ( Figure 1A-D ), suggesting that dtau may mediate neurotoxicity induced by expanded G4C2 as well.
We then examined whether dtau and human tau are conserved in mediating the expanded G4C2induced toxicity by expressing htau4R in the neurons driven by elav-GAL4. htau4R expression restored (G4C2)30 induced neurodegeneration, deficient motor performance and the shortened lifespan phenotypes in the dtau KO Drosophila ( Figure 1C -D), confirming that tau plays a conserved role in the expanded G4C2-induced neurodegeneration as well.
The expanded G4C2 increased tau protein levels in Drosophila and human cells
We then explored potential mechanisms regarding how dtau influenced the expanded G4C2r-induced toxicity. There are two major possibilities: 1. dtau is an upstream regulator of expanded G4C2r expression; 2. dtau is a downstream factor that is modulated by expanded G4C2r and mediates its neurotoxicity. Thus, we first examined whether dtau knockout lowered the expanded G4C2r RNA, which is likely the fundamental source of neurotoxicity in this model . Since it is extremely difficult to amplify the G4C2 repeat region per se by quantitative PCR, we chose the upstream and downstream sequences for qPCR measurements ( Figure S3A ). We observed no significant change in expanded G4C2r mRNA levels in the dtau heterozygous knockout flies, suggesting that dtau is not an upstream regulator of expanded G4C2r expression ( Figure S3B ).
The evidence above suggested that dtau is more likely a downstream mediator of the expanded G4C2r-induced toxicity. We first examined potential missplicing of tau transcripts. Alternative splicing of exon 10 of MAPT gene results in tau isoforms containing either three or four microtubule-binding repeats (3R and 4R, respectively) (Liu and Gong, 2008) . Similar as the human tau, dtau proteins expressed from different tau transcripts ( Figure S3C ) contain either three or four putative tubulinbinding repeats (MTBDs) that are homologous with mammalian MTBDs (Heidary and Fortini, 2001 ).
In addition, all dtau proteins have an extra MTBD that is homologous with Caenorhabditis elegans but not mammalian ones. Thus, dtau have the 4R versus 3R isoforms due to alternative splicing (or 5R versus 4R if we consider the extra MTBD), corresponding to 4R versus 3R isoforms in human tau.
We thus measured different dtau transcript levels and the 3R/4R ratio in fly brains with (G4C2)30 expression versus the control (no repeat or (G4C2)3), and observed no significant changes in either the transcript levels or the 4R/3R ratio ( Figure S3D ), suggesting that the expanded G4C2r may not induce tau missplicing.
Increased level of tau protein is another possible driver of neurodegeneration. We thus investigated whether tau protein level is increased in the expanded G4C2r expressing Drosophila model.
Expression of expanded G4C2r ((G4C2)30) led to increased tau protein levels in tissue samples from 3 rd stage larvae, pupae and adult Drosophila (Figure 2A -C), suggesting that the expanded G4C2r expression increases tau accumulation. Consistent with the observation in Drosophila, exogenous expression of the expanded G4C2r ((G4C2)25) in HEK293T cells also resulted in tau protein accumulation ( Figure 2D ). We further investigated levels of tau aggregates, which is likely a toxic biomarker associated with tau accumulation. Consistently, HeLa cells with expanded G4C2r expression showed drastic increase of tau aggregates ( Figure 2E ), suggesting that expanded G4C2r is capable of enhancing aggregated form of tau as well.
We further investigated the levels of phosphorylated tau (p-tau), which is considered as a main toxic species that causes neurodegenerations. Western-blots of brains of adult Drosophila expressing expanded G4C2r showed an increase of certain forms of phosphorylated tau (p-tau) as detected by the p-tau antibody ps262 or AT8 ( Figure S4A ). Consistently, the p-tau increase by expanded G4C2r expression was observed in HEK293T cells as well ( Figure S4B ). The p-tau increase is likely a subsequence of increase tau accumulation ( We then explored the potential molecular mechanisms of autophagy impairment. Studies have found that BAG3 (BAG family molecular chaperone regulator 3), a key autophagy modulator (Kathage et al., 2017) , is negatively associated with tau protein levels (Ji et al., 2019; Lei et al., 2015) . We thus hypothesized that the expanded G4C2r expression may reduce BAG3 levels, leading to impaired autophagy function and tau accumulation. Consistent with this hypothesis, (G4C2)30 expression in Drosophila significantly reduced the mRNA levels of starvin (stv), the Drosophila orthologue of BAG3 (Arndt et al., 2010 ), compared to the (G4C2)3-expressing controls ( Figure 2G ). Due to a lack of antistarvin antibody, we examined potential BAG3 protein level changes in HEK293T cells, and observed consistent BAG3 lowering by the expanded G4C2r expression ( Figure 2H ). To further confirm that BAG3 may functionally modulate tau protein levels, we knocked-down BAG3 in HEK293T cells coexpressing (G4C2)25 and tau, and observed increased the tau level by lowering BAG3 expression ( Figure S6A ). Consistently, overexpressing BAG3 reduced tau levels ( Figure 2I ). Taken together, the expanded G4C2r expression decreased BAG3 levels, leading to impaired autophagy function and increased tau levels, or at least making a partial contribution of tau increase.
DISCUSSION
Taken together, our study revealed a functional role of tau in G4C2 mediated neurotoxicity. While some of the previous studies suggest a potential link between tau and G4C2 expansion, there has been no study demonstrating tau as a potential mediator of neurotoxicity induced by G4C2 expansion. Thus, we have made a novel discovery that tau may mediated the expanded G4C2rinduced neurotoxicity by showing that knockout of dtau mitigated in vivo neurodegeneration, motor performance deficits and shortened lifespan in the Drosophila G4C2 model ( Figure 2 ). While our study was mainly performed in the Drosophila model, tau's function in G4C2-induced neurotoxicity is likely conserved between human and flies. dtau has previously been cloned and demonstrated to displays microtubule-binding properties (Heidary and Fortini, 2001) , but its potential role in neurodegeneration has been controversial. Studies using either Drosophila RNAi lines or tau hypomorphic/deficiency lines led to contradictory results regarding the potential detrimental or beneficial effects of dtau removal, possibly because of off-target effects or incomplete removal of dtau, and there was no disease phenotype "restoration" experiments expressing human tau (htau) to test the functional similarity between dtau and htau. Meanwhile, dtau knockout did not trigger major effects in terms of fly survival and fly climbing ability ( Figure S1 & Figure 1 ), and it did not influence the toxic effects on fly survival related to the expression of human Aβ, suggesting that dtau may mediate neurodegeneration in certain context, and not in a nonspecific manner. On the other hand, our study demonstrated that expression of htau restored most phenotypes that were rescued by the dtau knockout ( Figure S1C BAG3-mediated autophagy may play a key role in maintaining cellular homeostasis under stress as well as during aging (reviewed by (Behl, 2016) ), when the increased demand for protein degradation enhances BAG3 expression, followed by a functional switch from BAG1-mediated proteasomal to BAG3-mediated autophagic pathway. Meanwhile, potential changes or functional roles of BAG3 in G4C2 models was previously unknown, and our study revealed a potential role of the conserved BAG3-autophagy pathway in the expanded G4C2r-induced neurotoxicity.
In summary, our study revealed an evolutionarily conserved BAG3-mediated autophagy-dependent mechanism between the expanded G4C2r-induced ALS and tauopathies, providing entry points for targeting these diseases. Figure 1A -B, but testing the expanded G4C2r induced toxicity. dtau KO significantly rescued in vivo neurodegeneration induced by (G4C2)30 expression. B) Representative images and quantifications of neurodegeneration in the neuromuscular junctions (NMJs) in flies with the indicated genotypes. NMJs of muscle 6/7 in abdominal segment A2 and A3 of third instar larvae were stained with anti-HRP (neuronal axon marker, red channel) and anti-Bruchpilot (Brp) (active zone marker, green channel). The Brp-positive active zones were reduced by (G4C2)30 expression, and rescued by dtau KO. The white arrows indicated the buttons of NMJs. Scale bars, 10 μm. C-D) Similar as Figure 1C -D, but for G4C2 flies. dtau KO significantly rescued motor function deficits and shortened lifespan induced by (G4C2)30 expression. For all plots in A-C, error bars indicate mean ± SEM. Asterisks denote statistically significant differences (*p≤0.05, **p≤0.01, ***p≤0.001，****p≤0.0001).
Figure 2. G4C2r expression increased tau protein levels in vivo and in cells via reducing BAG3-mediated autophagy.
A-C) Representative Western-blots and quantifications showing that the total tau levels were increased by (G4C2)30 expression in the 3rd instar larva, pupa and adult stage flies, compared to the (G4C2)3 expression controls. n indicates the number of individual flies. The statistical analysis was performed by two-tailed unpaired t tests. D) Representative immunofluorescence images of whole-mount fly brains showing increased transgenic htau levels in (G4C2)30 flies. All the flies was dissected and stained at day 16. E) Representative Western-blots and quantifications showing that total tau levels were increased by (G4C2)25 compared to (G4C2)3 controls in transfected HEK293T cells. The statistical analysis was performed by two-tailed unpaired t tests. F) Representative immunofluorescence images and quantifications (measured by the number of tau puncta per cell) showing that (G4C2)25 expression increased tau aggregates in HeLa cells, compared to the (G4C2)3 expressing controls. The statistical analysis was performed by two-tailed unpaired t tests. The aggregates were tested in HeLa cells, because tau aggregates were hardly visible in HEK293T cells. G) Representative Western-blots and quantifications showing that the cleaved product (free GFP cleaved from GFP-mCherry-atg8) band is largely missing in motor neurons expressing (G4C2)30, suggesting an inhibition of autophagy activity in these neurons. n indicates the number of individual flies. The statistical analysis was performed by two-tailed unpaired t tests. H) qPCR showing a reduction of starvin (stv) mRNA levels by (G4C2)30 expression compared to the (G4C2)3 expressing controls. The results were consistent in both elav(I)-GAL4 or elav(III)-GAL4 driven flies. I) Representative Western-blots and quantifications of lysates from transfected HEK293T cells showing that BAG3 protein levels were reduced by (G4C2)25 expression compared to the (G4C2)3 expressing controls. For all plots, bars indicate mean ± SEM. Asterisks denote statistically significant differences (*p≤0.05, **p≤0.01, ***p≤0.001，****p≤0.0001). Figure S1 . dtau knockout rescued in vivo neurodegeneration, motor function deficits, and shortened lifespan in HD flies. A) Representative immunofluorescence images of whole-mount brains of flies of indicated genotypes at indicated ages showing in vivo neurodegeneration. The morphology of small ventral lateral (sLNv) clock neurons was labeled by mCD8GFP protein, which was driven by GMR61G12-GAL4. The HTT.ex1.Q72 or HTT.ex1.Q25 expression was also driven by the same GAL4. The white arrows indicated a major axon bundle that were degenerated in the HTT.ex1.Q72 expressing flies, compared to the HTT.ex1.Q25 expressing or the w1118 control flies. 
SUPPLEMENTARY FIGURES

Figure S2. Validation of neurodegeneration detection by axon and dendrite markers.
Representative immunofluorescence images of whole-mount brains from Drosophila of indicated genotypes. The expression of axon marker (syt.eGFP) or the dendrite marker (DenMarker) were driven by GMR61G12-GAL4 in the sLNv clock neurons with HTT.ex1.Q25 or HTT.ex1.Q72 expression, or in the wild-type background (w1118). Obvious neurodegeneration could be detected in both axons and dendrites by HTT.ex1.Q72 expression.
Figure S3. dtau and the expanded G4C2r did not influence each other's mRNA levels.
A) The schematic picture of the qPCR primers for measurements of the (G4C2)30 transcript level. B) qPCR measurements of (G4C2)30 transcripts in brain tissues from flies of indicated genotypes using indicated qPCR primers. n indicates the number of individual flies. The statistical analysis was performed by two-tailed unpaired t tests. C) The schematic picture of the qPCR primers for measurements of the endogenous dtau transcript level. D) qPCR measurements of the indicated dtau transcripts in brain tissues from flies of indicated genotypes. The statistical analysis was performed by two-tailed unpaired t tests. Neither the dtau transcript levels nor their splicing were influenced by (G4C2)30 compared to (G4C2)3. For all plots, bars indicate mean ± SEM. Asterisks denote statistically significant differences (*p≤0.05, **p≤0.01, ***p≤0.001，****p≤0.0001). For all the qPCR primers tested, the no reverse transcriptase control showed no amplification, validating that the signals were not contaminated by genomic DNA.
Figure S4. G4C2r expression increased certain forms of phosphorylated tau protein levels in vivo and in cells.
A) Representative Western-blots and quantifications showing that the phosphorylated tau levels detected by the antibody pS262 or AT8 were increased by (G4C2)30 expression in the adult fly heads, compared to the (G4C2)3 expressing controls. n indicates the number of biological replicates. The statistical analysis was performed by two-tailed unpaired t tests. B) Similar as A, but in transfected HEK293T cells. A-C) Representative Western-blots of HEK293T and fly samples showing the specificity of anti-total tau and phos-tau, including htau, pS262 and AT8 antibodies. The representative Western-blots in A) also showed that BAG3 knock-down increased tau (detected by the antibody 5A6) levels. caused lethality in early development as described previously . As the pupal lethality of (G4C2)30 driven by elav(I)-GAL4 precluded studies in mature neurons of the adult brain, and thus we used elav(II)-GAL4 or elav(III)-GAL4 for substituting it and overcome the shortage. UAS-HTT.ex1.Q25 and UAS-HTT.ex1.Q72 were generated by injecting pUAST-HTT.ex1.Q25 or pUAST-HTT.ex1.Q72 plasmid with helper-plasmids named Δ2-3 into w1118.
MATERIAL AND METHODS
Fly stocks and genetics
Behavioral and lifespan experiments
For behavioral experiments (climbing assay), we placed 15 age-matched virgin female flies in an empty vial and tapped them down. The percentage of flies that climbed past a 9-cm-high line after 15 s was recorded. The mean of five observations is plotted for each vial on each day, and data from multiple vials containing different batches of flies were plotted and analyzed by two-way ANOVA tests. The flies were randomly placed into each tube. For lifespan measurements, we placed ≥60 age-matched virgin female flies in an empty plastic vial and recorded the survival situation for each vial on each day. For both behavioral and lifespan measurement experiments, the person who performed the experiments were blind to the genotypes until data analysis. The survival distribution of the two genotypic groups were compared using the log-rank (Mantel-Cox) test.
Plasmids used for fly strain generation and mammalian cell transfection
The HTT.ex1.Q25 and HTT.ex1.Q72 cDNA were achieved by PCR amplification from pcDNA-HTT.ex1.Q25 and pcDNA-HTT.ex1.Q72 plasmid, and they were cloned into pUAST vector. The tausnap plasmid were generated by inserting the cDNA expressing one transcript of human tau (0N4R, cloned by PCR amplification from the UAS-htau4R Drosophila strain) into the snap-tag vector (NEB, cat. no. P9312S). (G4C2)3 and (G4C2)25 plasmids were generated by inserting (g4c2)3 or (g4c2)25 repeats into pTT-sfGFP vector . The (g4c2)3 repeats was achieved by primer annealing process and (g4c2)25 repeats was achieved with using the enzyme to cut the plasmid named pHR-Tre3G-29xGGGGCC-12xMS2 (addgene, cat.no. #99149). The BAG3 vector was constructed by cloning human BAG3 cDNA sequence from PUC57_BAG3wt-eGFP (addgene,cat.no. #98182) into pTT-sfGFP vector. As the end of PCR product BAG3 gene was with termination codon, GFP protein in the vector was not expressed with BAG3 protein.
Immunostaining
For immunofluorescence of cultured HeLa cells (Figure 2E , cells were fixed in 4% paraformaldehyde (PFA) at room temperature for 10 min after washing with 1× PBS for three times (20 minutes each), and then washing and permeabilized in 0.5% (vol/vol) TritonX-100 for 10 min. The cells were then blocked in blocking buffer (4% BSA + 0.1% (vol/vol) Triton X-100 in 1× PBS) for 30 min and incubated overnight at 4 °C with the primary antibody (anti-tau antibody, DSHB, 5A6), and then washed three times with blocking buffer and incubated with secondary antibody at room temperature for 1 h.
Coverslips were then washed three times, stained with 0.5 mg/ml DAPI for 5 minutes at room temperature, and then mounted in vectashield mounting medium (Vector, cat.no. H-1002). Images were taken by Zeiss Axio Vert A1 confocal microscopes and analyzed blindly by ImageJ for htau puncta numbers in each cell.
For imaging of in vivo neurodegeneration in the fly brains ( Figure S1A 
Western-blot experiments and antibodies
For protein extraction from the fly tissues, the samples (brains or whole bodies) were dissected on ice and homogenized with a tissue grinder for 5 min at 60 Hz and lysed on ice for 60 min in the lysis (1× RIPA buffer (Beyotime, cat. no. #P0013B) + 1× Complete protease inhibitor (Roche, cat. no. 4693159001)). The samples were then sonicated for 10 cycles, 15 s on and 20 s off, and then collected. The whole lysates were then loaded onto the 4-12% bis-tris gradient gel for Western-blots.
For the Western-blots of ubiquitinated proteins and ref(2)P ( Figure S5 ), the lysates were centrifuged at > 20,000g at 4℃ for 30 min. The precipitates were then collected and loaded for Western-blots. For protein extraction from cells, the cell pellets were collected and lysed on ice for 30 minutes in 2% SDS (in 1× PBS + 1× Complete protease inhibitor (Roche, cat. no. 4693159001)) and sonicated for 10 cycles, 15 s on and 20 s off. The whole lysates were then collected and loaded for Western-blots.
Antibodies used for Western-blots and immunostaining
anti-Brp (DSHB, cat. no. AB 2314866,); anti-htau (clone 5A6, detecting total human tau, DSHB, cat.
no. AB 528487); anti-Actin (Millipore, cat. no. 92590); anti-β-Tubulin (Abcam, cat.no. #ab6046); antiref(2)P (Abcam, cat. no. #ab178440); anti-GFP (ProteinTech, cat. no. 50430-2-AP); anti-BAG3 (ProteinTech, cat. no. 10599-1-AP,); anti-ubiquitin (Dako, cat. no. Z0458); AT8 (detecting phosphorylated-tau, ThermoFisher, cat.no. MN1020); pS262 (detecting Ser262 phosphorylated-tau, ThermoFisher, cat. no. OPA1-03142); pS199 (detect Ser199 phosphorylated-tau, ThermoFisher, #701054). All the antibodies' specificity has been validated in this study ( Figure S6 ) or in previous literature (such as cited or indexed in Antibodypedia).
RNA extraction and RT-qPCR
RNA from fly tissues or cells was extracted using RNAprep Kit (Tiangen, #DP419) followed by purification using the RNA-clean kit (Tiangen, #DP412) to remove proteins and RNase-free DNase I (Tiangen, #RT411) treatment to break down the genomic DNA. cDNA was obtained by reverse transcription using the FastQuant RT Kit with the oligo (dT) primer (Takara, #RR047A). qPCR was then performed using SYBR Green Realtime PCR Master Mix (Toyobo, #QPK-201). All the primers were published and validated previously, and further tested for standard curve and melting curve.
Amplification efficiency was between 95%-105% and the R 2 for linear relationship is > 0.999 for all primers. No reverse-transcriptase controls were used to ensure the specificity of the signals. qPCR primer sequences were as follows:
3R+4R-F 5'ggcggcgagaagaagata3'
